Centre Hospitalier Universitaire de Strasbourg

Strasbourg 67091

0 studies enrolling now · 3 studies all time

What they study most

Alström Syndrome (AS), Bardet Biedl Syndrome (BBS), Chronic Hepatitis C, Compensated Cirrhosis, Nonalcoholic Steatohepatitis

Studies at this site

• Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity — Completed
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed